Leptin gene therapy in the fight against diabetes

Bibliography

• Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004;89:2601-7
   PubMed Web of Science ®Google Scholar
• Kalra SP. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 2008;29:127-38
   PubMed Web of Science ®Google Scholar
• Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70
   PubMed Web of Science ®Google Scholar
• Kalra SP, Dube MG, Pu S, Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100
   PubMed Web of Science ®Google Scholar
• Kalra SP. Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches. Nutrition 2008;24:820-6
   PubMed Web of Science ®Google Scholar
• Otukonyong EE, Dube MG, Torto R, Central leptin differentially modulates ultradian secretory patterns of insulin, leptin and ghrelin independent of effects on food intake and body weight. Peptides 2005;26:2559-66
   PubMed Web of Science ®Google Scholar
• Otukonyong EE, Dube MG, Torto R, High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obes Res 2005;13:991-9
   PubMedGoogle Scholar
• Kojima S, Asakawa A, Amitani H, Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides 2009;30:962-6
   PubMed Web of Science ®Google Scholar
• Beretta E, Dhillon H, Kalra PS, Kalra SP. Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods. Peptides 2002;23:975-84
   PubMed Web of Science ®Google Scholar
• Standards of medical care in diabetes – 2008. Diabetes Care 2008;31(Suppl 1):S12-54
   PubMed Web of Science ®Google Scholar
• Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001;414:821-7
   PubMed Web of Science ®Google Scholar
• Campbell RK. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc (2003) 2009;49(Suppl 1):S3-9
   Google Scholar
• Luo X, Herold KC, Miller SD. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 2010;32:488-99
   PubMed Web of Science ®Google Scholar
• Kalra PS, Kalra SP. Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy. Drugs Today (Barc) 2002;38:745-57
   PubMed Web of Science ®Google Scholar
• Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001;358:739-46
   PubMed Web of Science ®Google Scholar
• Taubes G. Diabetes. Paradoxical effects of tightly controlled blood sugar. Science 2008;322:365-7
   PubMed Web of Science ®Google Scholar
• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-6
   PubMed Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB, Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:17-30
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32
   PubMed Web of Science ®Google Scholar
• Campfield LA, Smith FJ, Guisez Y, Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9
   PubMed Web of Science ®Google Scholar
• Halaas JL, Gajiwala KS, Maffei M, Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-6
   PubMed Web of Science ®Google Scholar
• Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005;366:74-85
   PubMed Web of Science ®Google Scholar
• Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130:671-80
   PubMed Web of Science ®Google Scholar
• Bado A, Levasseur S, Attoub S, The stomach is a source of leptin. Nature 1998;394:790-3
   PubMed Web of Science ®Google Scholar
• Masuzaki H, Ogawa Y, Sagawa N, Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997;3:1029-33
   PubMed Web of Science ®Google Scholar
• Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997;272:32686-95
   PubMed Web of Science ®Google Scholar
• Tartaglia LA, Dembski M, Weng X, Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Masuzaki H, Hosoda K, Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 1999;48:1822-9
   PubMed Web of Science ®Google Scholar
• Bagnasco M, Dube MG, Kalra PS, Kalra SP. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 2002;143:4409-21
   PubMed Web of Science ®Google Scholar
• Montague CT, Farooqi IS, Whitehead JP, Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8
   PubMed Web of Science ®Google Scholar
• Murphy JE, Zhou S, Giese K, Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc Natl Acad Sci USA 1997;94:13921-6
   PubMed Web of Science ®Google Scholar
• Halaas JL, Boozer C, Blair-West J, Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997;94:8878-83
   PubMed Web of Science ®Google Scholar
• Ueno N, Dube MG, Inui A, Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 2004;145:4176-84
   PubMed Web of Science ®Google Scholar
• Keen-Rhinehart E, Kalra SP, Kalra PS. AAV-mediated leptin receptor installation improves energy balance and the reproductive status of obese female Koletsky rats. Peptides 2005;26:2567-78
   PubMed Web of Science ®Google Scholar
• Saladin R, De Vos P, Guerre-Millo M, Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527-9
   PubMed Web of Science ®Google Scholar
• Sivitz WI, Walsh SA, Morgan DA, Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997;138:3395-401
   PubMed Web of Science ®Google Scholar
• Dhillon H, Ge Y, Minter RM, Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regul Pept 2000;92:97-105
   PubMed Web of Science ®Google Scholar
• Bagnasco M, Dube MG, Katz A, Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obes Res 2003;11:1463-70
   PubMedGoogle Scholar
• Dhillon H, Kalra SP, Kalra PS. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther 2001;4:139-45
   PubMed Web of Science ®Google Scholar
• Ebihara K, Kusakabe T, Hirata M, Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 2007;92:532-41
   PubMed Web of Science ®Google Scholar
• Kamohara S, Burcelin R, Halaas JL, Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374-7
   PubMed Web of Science ®Google Scholar
• Pelleymounter MA, Cullen MJ, Baker MB, Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-3
   PubMed Web of Science ®Google Scholar
• Miles PD, Yamatani K, Lickley HL, Vranic M. Mechanism of glucoregulatory responses to stress and their deficiency in diabetes. Proc Natl Acad Sci USA 1991;88:1296-300
   PubMed Web of Science ®Google Scholar
• Cornier MA, Dabelea D, Hernandez TL, The metabolic syndrome. Endocr Rev 2008;29:777-822
   PubMed Web of Science ®Google Scholar
• Kalra SP. Circumventing leptin resistance for weight control. Proc Natl Acad Sci USA 2001;98:4279-81
   PubMed Web of Science ®Google Scholar
• Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol Endocrinol Metab 2000;278:E1-14
   PubMed Web of Science ®Google Scholar
• Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-29
   PubMed Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 2000;16:145-71
   PubMed Web of Science ®Google Scholar
• Sorisky A. From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus. Crit Rev Clin Lab Sci 1999;36:1-34
   PubMed Web of Science ®Google Scholar
• Gillet JP, Macadangdang B, Fathke RL, The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer. Methods Mol Biol 2009;542:5-54
   PubMedGoogle Scholar
• Yuge K, Takahashi T, Nagano S, Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma. Int J Oncol 2005;27:77-85
   PubMed Web of Science ®Google Scholar
• Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev 1993;3:499-503
   PubMed Web of Science ®Google Scholar
• Khai NC, Takahashi T, Ushikoshi H, In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF. J Hepatol 2006;44:1046-54
   PubMed Web of Science ®Google Scholar
• Kagawa T, Takemura G, Kosai K, Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice. Nephron Physiol 2006;102:92-102
   Web of Science ®Google Scholar
• Ushikoshi H, Takahashi T, Chen X, Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes. Lab Invest 2005;85:862-73
   PubMed Web of Science ®Google Scholar
• Tada T, Nguyen JB, Hitoshi Y, Diffuse encephaloventriculitis and substantial leukoencephalopathy after intraventricular administration of recombinant adenovirus. Neurol Res 2005;27:378-86
   PubMed Web of Science ®Google Scholar
• Li Y, Takemura G, Kosai K, Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 2003;107:2499-506
   PubMed Web of Science ®Google Scholar
• Terazaki Y, Yano S, Yuge K, An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice. Hepatology 2003;37:155-63
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kawai T, Ushikoshi H, Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting. Mol Ther 2006;14:673-83
   PubMed Web of Science ®Google Scholar
• Nadeau I, Kamen A. Production of adenovirus vector for gene therapy. Biotechnol Adv 2003;20:475-89
   PubMed Web of Science ®Google Scholar
• Alemany R. Designing adenoviral vectors for tumor-specific targeting. Methods Mol Biol 2009;542:57-74
   Google Scholar
• Morsy MA, Gu M, Motzel S, An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci USA 1998;95:7866-71
   PubMed Web of Science ®Google Scholar
• Kamizono J, Nagano S, Murofushi Y, Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication. Cancer Res 2005;65:5284-91
   PubMed Web of Science ®Google Scholar
• Nagano S, Oshika H, Fujiwara H, An efficient construction of conditionally replicating adenoviruses that target tumor cells with multiple factors. Gene Ther 2005;12:1385-93
   PubMed Web of Science ®Google Scholar
• Grieger JC, Samulski RJ. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 2005;99:119-45
   PubMed Web of Science ®Google Scholar
• Schultz BR, Chamberlain JS. Recombinant adeno-associated virus transduction and integration. Mol Ther 2008;16:1189-99
   PubMed Web of Science ®Google Scholar
• Flotte TR, Carter BJ. Adeno-associated virus vectors for gene therapy. Gene Ther 1995;2:357-62
   PubMed Web of Science ®Google Scholar
• Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989;63:3822-8
   PubMed Web of Science ®Google Scholar
• Flotte TR, Afione SA, Conrad C, Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993;90:10613-17
   PubMed Web of Science ®Google Scholar
• Koeberl DD, Alexander IE, Halbert CL, Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci USA 1997;94:1426-31
   PubMed Web of Science ®Google Scholar
• Fisher KJ, Jooss K, Alston J, Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-12
   PubMed Web of Science ®Google Scholar
• Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996;70:8098-108
   PubMed Web of Science ®Google Scholar
• Kaplitt MG, Leone P, Samulski RJ, Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994;8:148-54
   PubMed Web of Science ®Google Scholar
• Kaplitt MG, Xiao X, Samulski RJ, Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg 1996;62:1669-76
   PubMed Web of Science ®Google Scholar
• Liu X, Luo M, Guo C, Analysis of adeno-associated virus progenitor cell transduction in mouse lung. Mol Ther 2009;17:285-93
   PubMed Web of Science ®Google Scholar
• Mueller C, Flotte TR. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 2008;15:858-63
   PubMed Web of Science ®Google Scholar
• Kosai KI, Finegold MJ, Thi-Huynh BT, Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. Hum Gene Ther 1998;9:1293-301
   PubMed Web of Science ®Google Scholar
• Ikoma T, Takahashi T, Nagano S, A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. Clin Cancer Res 2004;10:1192-200
   Google Scholar
• Muzzin P, Eisensmith RC, Copeland KC, Woo SL. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 1996;93:14804-8
   PubMed Web of Science ®Google Scholar
• Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994;1:433-42
   PubMed Web of Science ®Google Scholar
• Yang Y, Nunes FA, Berencsi K, Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994;91:4407-11
   PubMed Web of Science ®Google Scholar
• Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355-65
   PubMed Web of Science ®Google Scholar
• Couri CE, Voltarelli JC. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetol Metab Syndr 2009;1:19
   PubMedGoogle Scholar
• Van Heek M, Compton DS, France CF, Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997;99:385-90
   PubMed Web of Science ®Google Scholar
• Levin BE, Dunn-Meynell AA, Banks WA. Obesity-prone rats have normal blood–brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 2004;286:R143-50
   PubMed Web of Science ®Google Scholar
• Munzberg H, Myers Jr MG. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005;8:566-70
   PubMed Web of Science ®Google Scholar
• Dhillon H, Kalra SP, Prima V, Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept 2001;99:69-77
   PubMed Web of Science ®Google Scholar
• Ueno N, Inui A, Kalra PS, Kalra SP. Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides 2006;27:2332-42
   PubMed Web of Science ®Google Scholar
• Boghossian S, Ueno N, Dube MG, Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin. Neurobiol Aging 2007;28:1594-604
   PubMed Web of Science ®Google Scholar
• Kalra SP. Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation. Peptides 2009;30:1957-63
   PubMed Web of Science ®Google Scholar
• Boghossian S, Lecklin A, Torto R, Suppression of fat deposition for the life time with gene therapy. Peptides 2005;26:1512-19
   PubMed Web of Science ®Google Scholar
• Kalra SP, Kalra PS. Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy. Trends Pharmacol Sci 2005;26:488-95
   PubMed Web of Science ®Google Scholar
• Aiuti A, Roncarolo MG. Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematol Educ Program 2009:682-9
   PubMedGoogle Scholar
• Carmen IH. A death in the laboratory: the politics of the Gelsinger aftermath. Mol Ther 2001;3:425-8
   PubMed Web of Science ®Google Scholar
• Raper SE, Chirmule N, Lee FS, Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003;80:148-58
   PubMed Web of Science ®Google Scholar
• Frank KM, Hogarth DK, Miller JL, Investigation of the cause of death in a gene-therapy trial. N Engl J Med 2009;361:161-9
   PubMed Web of Science ®Google Scholar
• Kaiser J. Clinical trials. Gene transfer an unlikely contributor to patient's death. Science 2007;318:1535
   PubMed Web of Science ®Google Scholar